by George Ciuciureanu | Jun 6, 2025 | Events, Health
Augurex to attend BIO 2025, June 16–19, in Boston, MA, the world’s largest biotechnology partnering event. Showcasing biomarker-based diagnostics for rheumatoid arthritis and axial spondyloarthritis, including JOINTstat® and first-in-class SPINEstat™. Vancouver,...
by George Ciuciureanu | Jun 5, 2025 | Health, News
Take a Pain Check Foundation features a new blog highlighting Augurex’s 14-3-3eta biomarker. The blog post explores how biomarkers improve diagnosis and personalized care in rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA). Vancouver, Canada – June 5,...
by George Ciuciureanu | Jun 4, 2025 | Events, Health
Augurex to present a poster and share a second accepted abstract at EULAR 2025, taking place June 11–14 in Barcelona. New findings highlight the value of 14-3-3eta autoantibodies in improving early detection of axSpA, including in HLA-B27–negative patients. Vancouver,...
by George Ciuciureanu | Apr 30, 2025 | Events, Health
Augurex to participate in the SPARTAN 2025 Annual Meeting, taking place May 9–10 in Toronto, Canada. Featuring SPINEstat™, a Health Canada-approved, first-in-class blood test for the early diagnosis and monitoring of axial spondyloarthritis (axSpA). Vancouver, Canada...
by George Ciuciureanu | Apr 25, 2025 | Events, Health
Augurex to attend British Society for Rheumatology 2025 Annual Meeting in Manchester, UK Highlighting biomarker-based diagnostic innovations for RA and axSpA Vancouver, Canada – April 25, 2025 – Augurex Life Sciences Corp., a leader in biomarker-based diagnostics for...
by George Ciuciureanu | Apr 24, 2025 | Events, Health
Augurex to attend CCR East 2025 and present new research on 14-3-3eta auto-antibodies as a diagnostic marker for axial spondyloarthritis (axSpA). Augurex will be exhibiting at booth #66, showcasing how the 14-3-3eta test aids in the diagnosis and monitoring of...
